Insulin-resistant cells cannot properly respond to insulin or use glucose from the blood and the resulting disturbances in lipid and glucose metabolism stimulate the further development of metabolic inflammation and metabolic syndrome (MS) [1,2]. Here, INS is linked to myeloid sarcoma.